Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27β DNA probe

About 80% to 90% of females are informative for X-inactivation/methylation analysis with the probe M27 beta, which would therefore seem attractive in assessing clonality in hematologic cell populations. Eighteen acute lymphoid or myeloid leukemias, three chronic lymphocytic leukemias, and three chro...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 83; no. 4; pp. 931 - 938
Main Authors FEY, M. F, LIECHTI-GALLATI, S, VON ROHR, A, BORISCH, B, THEILKÄS, L, SCHNEIDER, V, OESTREICHER, M, NAGEL, S, ZIEMIECKI, A, TOBLER, A
Format Journal Article
LanguageEnglish
Published Washington, DC The Americain Society of Hematology 15.02.1994
Subjects
Online AccessGet full text

Cover

Loading…
Abstract About 80% to 90% of females are informative for X-inactivation/methylation analysis with the probe M27 beta, which would therefore seem attractive in assessing clonality in hematologic cell populations. Eighteen acute lymphoid or myeloid leukemias, three chronic lymphocytic leukemias, and three chronic myelogenous leukemias as well as 12 malignant non-Hodgkin's lymphomas mostly showed extremely skewed clonal X inactivation (median allelic cleavage ratio [ACR] of unmethylated/inactive M27 beta alleles was 50, range 1 to 100) or hypermethylation of both alleles. Two lymphomas showed random M27 beta X inactivation but clonal antigen-receptor gene rearrangements. In normal peripheral blood leukocytes from 105 healthy females aged 2 to 96 years, the median ACR was 2 (range 1 to 100). Thus, it was significantly lower than in the leukemias (P = .0001, Mann-Whitney test), but extremely skewed patterns (ACR > 10.8, ie, > 80th percentile) were seen not only in the leukemias but also in 21/105 samples (20%) of normal leukocytes, and significantly more frequent in a population of elderly women (aged 75 to 96 years) compared with healthy children (aged 2 to 8 years) and younger women (aged 20 to 58 years) (P = .00125; chi 2 test). We conclude that in a population of cells derived from the hematopoietic system where clonality is uncertain, skewed M27 beta patterns are not reliable indicators for the presence of a clonal neoplastic disorder. The basis for severe X-inactivation skewing is unclear at present, but this finding raises interesting questions regarding the composition of the hematopoietic stem cell pool.
AbstractList Abstract About 80% to 90% of females are informative for X- inactivation/methylation analysis with the probe M27 beta, which would therefore seem attractive in assessing clonality in hematologic cell populations. Eighteen acute lymphoid or myeloid leukemias, three chronic lymphocytic leukemias, and three chronic myelogenous leukemias as well as 12 malignant non-Hodgkin's lymphomas mostly showed extremely skewed clonal X inactivation (median allelic cleavage ratio [ACR] of unmethylated/inactive M27 beta alleles was 50, range 1 to 100) or hypermethylation of both alleles. Two lymphomas showed random M27 beta X inactivation but clonal antigen-receptor gene rearrangements. In normal peripheral blood leukocytes from 105 healthy females aged 2 to 96 years, the median ACR was 2 (range 1 to 100). Thus, it was significantly lower than in the leukemias (P = .0001, Mann-Whitney test), but extremely skewed patterns (ACR > 10.8, ie, >80th percentile) were seen not only in the leukemias but also in 21/105 samples (20%) of normal leukocytes, and significantly more frequent in a population of elderly women (aged 75 to 96 years) compared with healthy children (aged 2 to 8 years) and younger women (aged 20 to 58 years) (P =.00125; chi 2 test). We conclude that in a population of cells derived from the hematopoietic system where clonality is uncertain, skewed M27 beta patterns are not reliable indicators for the presence of a clonal neoplastic disorder. The basis for severe X-inactivation skewing is unclear at present, but this finding raises interesting questions regarding the composition of the hematopoietic stem cell pool.
About 80% to 90% of females are informative for X-inactivation/methylation analysis with the probe M27 beta, which would therefore seem attractive in assessing clonality in hematologic cell populations. Eighteen acute lymphoid or myeloid leukemias, three chronic lymphocytic leukemias, and three chronic myelogenous leukemias as well as 12 malignant non-Hodgkin's lymphomas mostly showed extremely skewed clonal X inactivation (median allelic cleavage ratio [ACR] of unmethylated/inactive M27 beta alleles was 50, range 1 to 100) or hypermethylation of both alleles. Two lymphomas showed random M27 beta X inactivation but clonal antigen-receptor gene rearrangements. In normal peripheral blood leukocytes from 105 healthy females aged 2 to 96 years, the median ACR was 2 (range 1 to 100). Thus, it was significantly lower than in the leukemias (P = .0001, Mann-Whitney test), but extremely skewed patterns (ACR > 10.8, ie, > 80th percentile) were seen not only in the leukemias but also in 21/105 samples (20%) of normal leukocytes, and significantly more frequent in a population of elderly women (aged 75 to 96 years) compared with healthy children (aged 2 to 8 years) and younger women (aged 20 to 58 years) (P = .00125; chi 2 test). We conclude that in a population of cells derived from the hematopoietic system where clonality is uncertain, skewed M27 beta patterns are not reliable indicators for the presence of a clonal neoplastic disorder. The basis for severe X-inactivation skewing is unclear at present, but this finding raises interesting questions regarding the composition of the hematopoietic stem cell pool.
Author BORISCH, B
SCHNEIDER, V
TOBLER, A
FEY, M. F
ZIEMIECKI, A
LIECHTI-GALLATI, S
OESTREICHER, M
VON ROHR, A
NAGEL, S
THEILKÄS, L
Author_xml – sequence: 1
  givenname: M. F
  surname: FEY
  fullname: FEY, M. F
  organization: Inst. medical oncology, 3010 Berne, Switzerland
– sequence: 2
  givenname: S
  surname: LIECHTI-GALLATI
  fullname: LIECHTI-GALLATI, S
  organization: Inst. medical oncology, 3010 Berne, Switzerland
– sequence: 3
  givenname: A
  surname: VON ROHR
  fullname: VON ROHR, A
  organization: Inst. medical oncology, 3010 Berne, Switzerland
– sequence: 4
  givenname: B
  surname: BORISCH
  fullname: BORISCH, B
  organization: Inst. medical oncology, 3010 Berne, Switzerland
– sequence: 5
  givenname: L
  surname: THEILKÄS
  fullname: THEILKÄS, L
  organization: Inst. medical oncology, 3010 Berne, Switzerland
– sequence: 6
  givenname: V
  surname: SCHNEIDER
  fullname: SCHNEIDER, V
  organization: Inst. medical oncology, 3010 Berne, Switzerland
– sequence: 7
  givenname: M
  surname: OESTREICHER
  fullname: OESTREICHER, M
  organization: Inst. medical oncology, 3010 Berne, Switzerland
– sequence: 8
  givenname: S
  surname: NAGEL
  fullname: NAGEL, S
  organization: Inst. medical oncology, 3010 Berne, Switzerland
– sequence: 9
  givenname: A
  surname: ZIEMIECKI
  fullname: ZIEMIECKI, A
  organization: Inst. medical oncology, 3010 Berne, Switzerland
– sequence: 10
  givenname: A
  surname: TOBLER
  fullname: TOBLER, A
  organization: Inst. medical oncology, 3010 Berne, Switzerland
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3940530$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/8111064$$D View this record in MEDLINE/PubMed
BookMark eNo9kMmOEzEQhi00aMgMPAFC8gFx61BeevFxFFZpgAsgbla1u5oYOXbTdiKFx-JBeCY6M9EcSnX4lyp9V-wipkiMPRewFqKTr_uQ0rA-dGqt10aJ0zxiK1HLrgKQcMFWANBU2rTiCbvK-ReA0ErWl-yyE0JAo1fszyakiMGXI8c48B-Vj-iKP2DxKfIJS6E5Zu4j39IOS5qSp-IddxQCn9K0D3fOzAcq5AoNvD_ysiW-9T-34bgExzQvQX8g_km2__7yN59v-DSnnp6yxyOGTM_O-5p9e_f26-ZDdfvl_cfNzW3ltIZSdYA9gBnRkGyhcUZCQwQt1sIBUttpRBKqqw32UgCMhtA1ptfC9NBKoa7Zq_ve5ervPeVidz6f_sdIaZ9t26hmwakWo7o3ujnlPNNop9nvcD5aAfZE3N4Rt987ZbVdaJ9mSb041-_7HQ0PmTPiRX951jE7DOOM0fn8YFNGQ61A_QfvNY55
CitedBy_id crossref_primary_10_1182_blood_V89_1_128
crossref_primary_10_1097_MOL_0000000000000785
crossref_primary_10_1146_annurev_cancerbio_060121_120026
crossref_primary_10_1038_s41431_018_0291_3
crossref_primary_10_1006_mcpr_1997_0099
crossref_primary_10_1097_PAS_0b013e31815d6305
crossref_primary_10_17650_1818_8346_2023_18_3_92_101
crossref_primary_10_3390_cancers12082277
crossref_primary_10_1016_j_leukres_2023_107419
crossref_primary_10_1016_j_neuroscience_2006_01_060
crossref_primary_10_1034_j_1399_0004_2000_580504_x
crossref_primary_10_1053_j_seminhematol_2021_12_003
crossref_primary_10_1182_blood_V93_2_417
crossref_primary_10_1016_j_atherosclerosis_2020_02_008
crossref_primary_10_1038_s41591_021_01411_9
crossref_primary_10_1086_507565
crossref_primary_10_1111_j_1365_2141_1995_tb08422_x
crossref_primary_10_1007_s00395_022_00969_w
crossref_primary_10_1016_S0268_960X_97_90021_7
crossref_primary_10_1046_j_1365_2141_1998_00540_x
crossref_primary_10_1182_blood_V93_2_417_402a33_417_424
crossref_primary_10_1182_blood_V90_6_2213
crossref_primary_10_1007_s12185_011_0857_0
crossref_primary_10_1097_MOH_0000000000000631
crossref_primary_10_1161_ATVBAHA_122_318181
crossref_primary_10_1046_j_1440_1827_2003_01428_x
crossref_primary_10_1158_1078_0432_CCR_22_2598
crossref_primary_10_1002_pd_889
crossref_primary_10_1038_s41569_019_0247_5
crossref_primary_10_1007_BF02739689
crossref_primary_10_1007_s00439_016_1666_6
crossref_primary_10_1161_CIRCGEN_118_001926
crossref_primary_10_1182_blood_2002_07_2341
crossref_primary_10_1007_s10038_003_0040_4
crossref_primary_10_1182_blood_2017_02_769869
crossref_primary_10_3389_fonc_2022_957370
crossref_primary_10_3389_fonc_2023_1303785
crossref_primary_10_1182_bloodadvances_2019000770
crossref_primary_10_1002_stem_160038
crossref_primary_10_1016_j_pathol_2021_02_005
crossref_primary_10_1101_cshperspect_a036210
crossref_primary_10_1182_blood_2017_07_746453
crossref_primary_10_1093_jnci_91_4_339
crossref_primary_10_1038_s41408_022_00773_8
crossref_primary_10_1111_j_1600_0609_1998_tb01717_x
crossref_primary_10_1182_blood_2023022222
crossref_primary_10_1016_S0145_2126_02_00027_9
crossref_primary_10_1002__SICI_1096_8652_200004_63_4_184__AID_AJH4_3_0_CO_2_I
crossref_primary_10_1016_j_trsl_2022_11_004
crossref_primary_10_1086_302286
crossref_primary_10_1182_hem_V20_1_202312
crossref_primary_10_1016_j_beha_2019_02_006
crossref_primary_10_1182_blood_2016_01_636381
crossref_primary_10_1093_oxfordjournals_annonc_a010799
crossref_primary_10_1016_j_exphem_2019_12_001
crossref_primary_10_1007_BF01324809
crossref_primary_10_1038_s41568_021_00335_3
crossref_primary_10_1111_j_1600_0609_1995_tb00703_x
crossref_primary_10_1182_blood_V89_1_128_128_128_134
crossref_primary_10_1158_2159_8290_CD_21_0901
crossref_primary_10_1182_blood_V90_6_2213_2213_2213_2216
crossref_primary_10_1016_j_exphem_2019_12_006
crossref_primary_10_1002__SICI_1098_2744_199601_15_1_33__AID_MC5_3_0_CO_2_T
crossref_primary_10_1016_S0301_472X_02_00824_X
crossref_primary_10_3390_biology10020128
crossref_primary_10_1161_CIRCRESAHA_117_312115
crossref_primary_10_1016_j_retram_2023_103426
crossref_primary_10_3390_jmp2030021
crossref_primary_10_1186_1750_1172_5_14
crossref_primary_10_1146_annurev_genet_31_1_571
crossref_primary_10_1002__SICI_1096_8652_199808_58_4_263__AID_AJH2_3_0_CO_2_O
crossref_primary_10_1038_nm0396_281
crossref_primary_10_1016_j_critrevonc_2021_103311
crossref_primary_10_1016_j_semcancer_2017_09_008
crossref_primary_10_1126_science_aan4673
crossref_primary_10_1016_S0950_3536_98_80039_5
crossref_primary_10_1016_j_exphem_2020_01_008
crossref_primary_10_1182_blood_2002_07_2287
crossref_primary_10_3390_ijms22147663
crossref_primary_10_1016_j_canlet_2022_215691
crossref_primary_10_1016_j_jacc_2019_05_045
crossref_primary_10_3109_10428199709058326
crossref_primary_10_1016_S0272_2712_18_30076_3
crossref_primary_10_1002_stem_2845
crossref_primary_10_1046_j_1365_2141_1998_00867_x
crossref_primary_10_1016_j_exphem_2020_01_002
crossref_primary_10_1016_j_neo_2021_08_001
crossref_primary_10_3390_ijms21217902
ContentType Journal Article
Copyright 1994 INIST-CNRS
Copyright_xml – notice: 1994 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1182/blood.v83.4.931.931
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
Anatomy & Physiology
EISSN 1528-0020
EndPage 938
ExternalDocumentID 10_1182_blood_V83_4_931_931
8111064
3940530
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.55
.GJ
08R
1CY
23N
2WC
34G
39C
4.4
53G
5GY
5RE
5VS
6J9
9M8
AAEDW
AAQQT
AAUGY
AAXUO
ABOCM
ABPTK
ABVKL
ACGFO
ADBBV
AENEX
AFFNX
AFOSN
AI.
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BTFSW
C1A
CS3
DIK
DU5
E3Z
EBS
EJD
EX3
F5P
FDB
FRP
GS5
GX1
H13
IH2
IQODW
J5H
K-O
KQ8
L7B
LSO
MJL
MVM
N4W
N9A
OHT
OK1
P2P
R.V
RHF
RHI
ROL
SJN
THE
TR2
TWZ
UCJ
VH1
W2D
W8F
WH7
WHG
WOQ
WOW
X7M
YHG
YKV
ZA5
ZGI
ZXP
0R~
0SF
AALRI
ADVLN
AITUG
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c440t-80ab009fa9e2706c9206ee07a51c0ae784aae13859ab2100f9eac69b419b07213
ISSN 0006-4971
IngestDate Thu Oct 24 23:56:28 EDT 2024
Fri Aug 23 04:00:52 EDT 2024
Sat Sep 28 08:44:10 EDT 2024
Sun Oct 29 17:08:30 EDT 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Human
Cell culture
Hematopoiesis
DNA
Hematopoietic cell
Exploration
Molecular probe
X-Chromosome
Inactivation
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c440t-80ab009fa9e2706c9206ee07a51c0ae784aae13859ab2100f9eac69b419b07213
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://ashpublications.org/blood/article-pdf/83/4/931/613402/931.pdf
PMID 8111064
PQID 76361823
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_76361823
crossref_primary_10_1182_blood_V83_4_931_931
pubmed_primary_8111064
pascalfrancis_primary_3940530
PublicationCentury 1900
PublicationDate 1994-02-15
PublicationDateYYYYMMDD 1994-02-15
PublicationDate_xml – month: 02
  year: 1994
  text: 1994-02-15
  day: 15
PublicationDecade 1990
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
PublicationTitle Blood
PublicationTitleAlternate Blood
PublicationYear 1994
Publisher The Americain Society of Hematology
Publisher_xml – name: The Americain Society of Hematology
References 7919357 - Blood. 1994 Oct 1;84(7):2376-8
7919356 - Blood. 1994 Oct 1;84(7):2375-6
References_xml
SSID ssj0014325
Score 1.8283899
Snippet About 80% to 90% of females are informative for X-inactivation/methylation analysis with the probe M27 beta, which would therefore seem attractive in assessing...
Abstract About 80% to 90% of females are informative for X- inactivation/methylation analysis with the probe M27 beta, which would therefore seem attractive in...
SourceID proquest
crossref
pubmed
pascalfrancis
SourceType Aggregation Database
Index Database
StartPage 931
SubjectTerms Acute Disease
Adult
Aged
Aged, 80 and over
Aging - physiology
Base Sequence
Biological and medical sciences
Blotting, Southern
Cell differentiation, maturation, development, hematopoiesis
Cell physiology
Child
Child, Preschool
Chronic Disease
Cloning, Molecular
DNA Primers
DNA Probes
Female
Fundamental and applied biological sciences. Psychology
Hematopoiesis
Humans
Leukemia - blood
Leukemia - genetics
Leukocytes - physiology
Lymphoma, Non-Hodgkin - blood
Lymphoma, Non-Hodgkin - genetics
Methylation
Middle Aged
Molecular and cellular biology
Molecular Sequence Data
Polymerase Chain Reaction
Polymorphism, Genetic
Reference Values
Restriction Mapping
X Chromosome
Title Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27β DNA probe
URI https://www.ncbi.nlm.nih.gov/pubmed/8111064
https://search.proquest.com/docview/76361823
Volume 83
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJi4SQtAxUWDgB8ZLSXASN5fHNBRa6FqpdFX3FDmpwyqVtKIt0vaz9kP4TRw7TpqgIi4PjdJIdmR_X46Pj88FoVc8Trjj2C3NZjTSqEdjjcVUuImZYr0CsSzzFJwN7O45_ThtTWu1m5LX0nYT6fH13riS_0EVngGuIkr2H5AtOoUHcA_4whUQhutfYRwscj1amL-n2jwVYQqZkVVkTBXGPunvKjOzLlfLuQhZbApjfXNVVO5aN2dcHCUoXfRSJCH-crkQAYFKoxUFikznNOicts3mu4EvvLqiig9Re6GKzksudC6knVXfuQ33e52gO-5pH_x-3x_3KjbXyXDQHA27o6pldTjqfQ66kn47y0SWYtjUsthMPY9tU8dOMNDcCVUcT8gxF4cGuWS2RbW7jGdcCWORPZuYpCyts7I3ipW0JHo9tZpw9c_dv0C4IuGsDArQv7uWTnVopxdty-m4f1kmC-dFUUu-ZZFb6NAE4QZS9dBvTz71i7MraplZ3Qw1IpXrCt78ds97K_rQ_RVbw6eZZDVVfr_pkcrP-CF6oHYt2M8o-AjVeFpHR34KE_z1Cr_G0o9YznUd3W7nd3eDvJpgHd05U04cR-i6oC0G2uIqbXFOWzxPcYW2WNAWl2iLc9ri6AoDbXFGW1yiLQba_rjBQFksKfsYnb_vjIOupkqAaDGlZAP6E4N1wUuYx02H2LFnEptz4rCWERPGHZcyxg3LbXksMg1CEg8UCduLqOFFIvOfdYwO0mXKnyBMaUxmsD-yk4RTzg1mU5vwKOYeSUBLnTXQmxyIcJVlegnlDtk1Q4lbOHGtkIaAmfg10EkFrKKNokcDvczBC2GqxRSxlC-36xBWdBs6tRroOMO0aOqC4gFbhKd_6PoZurf73J6jg823LT8B1XgTvVBc_An3Zrn3
link.rule.ids 315,783,787,27936,27937
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clonality+and+X-inactivation+patterns+in+hematopoietic+cell+populations+detected+by+the+highly+informative+M27%CE%B2+DNA+probe&rft.jtitle=Blood&rft.au=FEY%2C+M.+F&rft.au=LIECHTI-GALLATI%2C+S&rft.au=VON+ROHR%2C+A&rft.au=BORISCH%2C+B&rft.date=1994-02-15&rft.pub=The+Americain+Society+of+Hematology&rft.issn=0006-4971&rft.eissn=1528-0020&rft.volume=83&rft.issue=4&rft.spage=931&rft.epage=938&rft_id=info:doi/10.1182%2Fblood.v83.4.931.931&rft.externalDBID=n%2Fa&rft.externalDocID=3940530
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-4971&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-4971&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-4971&client=summon